Atlas Trials

A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma

Clinical trial NCT01634685 · COMPLETED

Trial details

NCT number
NCT01634685
Sponsor
University of Texas Southwestern Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Rectal Adenocarcinoma
Start date
2012-08-08
Primary completion
2015-10-30
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.